Status:
UNKNOWN
Predictivity of Hemogasanalysis and Lung UltraSound in Determining COVID-19 Severity
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
This retrospective-prospective longitudinal observational study was designed to evaluate the role of bedside lung ultrasound per se and in association with hemogasanalysis parameters in predicting the...
Eligibility Criteria
Inclusion
- SARS - CoV 2 infection confirmed by positive RT-PCR on nasopharyngeal swab
Exclusion
- impossibility to perform lung ultrasound due to technical limitations.
Key Trial Info
Start Date :
December 16 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 10 2021
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04689672
Start Date
December 16 2020
End Date
May 10 2021
Last Update
December 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Raffaele
Milan, MI, Italy, 20132